A retrospective quasi-experimental cohort study among 516 patients receiving II (n = 284) or CI (n = 232) of CFZ for coronary artery bypass graft surgery found a 66% reduction in SSI with CI compared to II, although it did not reach statistical significance (1.7% vs. 4.6%, p = 0.116).
← all excerpts
Rationale and Logistics of Continuous Infusion Cephalosporin Antibiotics.
1
0.1160
0.1160